Eagle Pharmaceuticals Inc
NASDAQ:EGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
|
US |
|
P
|
Profithol SA
MAD:SPH
|
ES |
|
Willscot Mobile Mini Holdings Corp
NASDAQ:WSC
|
US |
|
S
|
Sparebank 1 SR Bank ASA
OSE:SRBNK
|
NO |
|
C
|
Cashbox Ventures Ltd
CNSX:CBOX.X
|
CA |
|
Permian Resources Corp
NYSE:PR
|
US |
|
E
|
eSang Networks Co Ltd
KOSDAQ:080010
|
KR |
|
H
|
Hyundai Hyms Co Ltd
KOSDAQ:460930
|
KR |
|
Sino Land Co Ltd
HKEX:83
|
HK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EGRX's stock price target?
Not Available
EGRX doesn't have any price targets made by Wall Street professionals.
What is Eagle Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-10%
For the last 8 years the
compound annual growth rate for
Eagle Pharmaceuticals Inc's revenue is
42%.
The projected
CAGR
for the next 3 years is
-10%.
What is Eagle Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-21%
The
compound annual growth rate
of Eagle Pharmaceuticals Inc's operating income for the next 3 years is
-21%.
What is Eagle Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
4%
The
compound annual growth rate
of Eagle Pharmaceuticals Inc's net income for the next 3 years is
4%.
